You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2007 or most recent year available [see all tables in this series...]

Part (ii) Outpatient clients by primary drug and mean age and gender ratio

Primary drug	Mean age	Gender ratio
Primary drug
Amphetamines	29	2
Ecstasy	24	3

Notes:

Countries providing data: BE, BG, CZ, DK, IE, EL, ES, FR, IT, CY , LU, HU, MT, NL, AT, RO, SI, SK, FI, SE, UK, HR

Data for Spain and Malta refer to 2006. Data for Belgium refer to 2005.

The number of treatment clients in each country is listed in <a href="https://www.emcdda.europa.eu/stats07/tditab7">Table TDI-7</a>.

See also 'General notes for interpreting data’ on the <a href="https://www.emcdda.europa.eu/stats07/help">Explanatory notes and help page</a>.

Sources:

<a href="https://www.emcdda.europa.eu/publications/national-reports">Reitox national reports 2008</a> — Standard table 3. See <a href="https://www.emcdda.europa.eu/stats08/tditab0">Table TDI-0</a> for details on sources. See also TDI-5.

Download this data in Excel (.xls) format

(see the help page for information about formats etc.)